Geometric impact and dose estimation of on-patient placement of a lightweight receiver coil in a clinical magnetic resonance imaging-only radiotherapy workflow for prostate cancer
- PMID: 37063614
- PMCID: PMC10091035
- DOI: 10.1016/j.phro.2023.100433
Geometric impact and dose estimation of on-patient placement of a lightweight receiver coil in a clinical magnetic resonance imaging-only radiotherapy workflow for prostate cancer
Abstract
Background and purpose: For pelvic magnetic resonance imaging (MRI)-only radiotherapy the use of receiver coil bridges (CB) is recommended to avoid deformation of the patient. Development in coil technology has enabled lightweight, flexible coils. In this work we evaluate the effects of a lightweight coil in a pelvic MRI-only radiotherapy workflow.
Materials and methods: Twenty-one patients, referred to prostate MRI-only radiotherapy, were included. Images were acquired with and without CB. Anatomical deformation from the on-patient coil placement was measured in the anterior-posterior (AP) and left-right (LR) direction. The change in signal-to-noise ratio (SNR) was measured in phantom and in vivo.The clinical treatment plan, created on the image with CB, was transferred and recalculated on the image without the CB. Dose metrics for the targets (planning- and clinical target volume) and organs at risks (OAR) were analyzed.
Results: There was a statistically significant increase in SNR in-vivo (median 21 %, p = 0.002) when removing the CB. Anatomical differences after removing the CB in patients were -1.5 mm in AP (median change) and + 2.5 mm in LR direction. Dosimetric differences for the target structures were clinically negligible, but statistically significant. The difference in target mean doses were 0.2 % (both p = 0.004) of the prescribed dose. No dosimetric differences were observed for the OAR, except for the penile bulb.
Conclusions: We concluded that anatomical change and dosimetric differences, originating from scanning without CB were minor. The CB can thereby be removed from the workflow, enabling easier patient positioning and increased SNR when using lightweight coils.
Keywords: Coil bridge; MRI-only; Prostate cancer; Radiotherapy.
© 2023 The Author(s).
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Author CJG gave an oral presentation which included a presentation fee on an ESTRO GE lunch symposium, Copenhagen, Denmark 2022. Main topic was MRI-only prostate treatment and the preliminary results of this study. No other authors declare any financial interests or personal relationships that can be considered as potential competing interests.
Figures




References
-
- Widmark A., Gunnlaugsson A., Beckman L., Thellenberg-Karlsson C., Hoyer M., Lagerlund M., et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet. 2019;394:385–395. doi: 10.1016/s0140-6736(19)31131-6. - DOI - PubMed
-
- Salembier C., Villeirs G., De Bari B., Hoskin P., Pieters B.R., Van Vulpen M., et al. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. Radiother Oncol. 2018;127:49–61. doi: 10.1016/j.radonc.2018.01.014. - DOI - PubMed
-
- Wegener D., Zips D., Thorwarth D., Weiss J., Othman A.E., Grosse U., et al. Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data. Acta Oncol. 2019;58:88–94. doi: 10.1080/0284186x.2018.1518594. - DOI - PubMed
LinkOut - more resources
Full Text Sources